- Drug Pipelines
- April 2025
- 240 Pages
Global
From €2627EUR$3,000USD£2,280GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1752EUR$2,000USD£1,520GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1752EUR$2,000USD£1,520GBP
- Report
- April 2025
- 200 Pages
Global
From €6963EUR$7,950USD£6,043GBP
- Drug Pipelines
- April 2025
- 240 Pages
Global
From €2627EUR$3,000USD£2,280GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1314EUR$1,500USD£1,140GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1095EUR$1,250USD£950GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1095EUR$1,250USD£950GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1095EUR$1,250USD£950GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1095EUR$1,250USD£950GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1095EUR$1,250USD£950GBP
- Report
- January 2026
- 182 Pages
Global
From €3941EUR$4,500USD£3,421GBP
- Clinical Trials
- April 2025
- 80 Pages
Global
From €1752EUR$2,000USD£1,520GBP
- Clinical Trials
- July 2025
- 80 Pages
Global
From €1752EUR$2,000USD£1,520GBP
- Report
- April 2025
- 200 Pages
Global
From €6963EUR$7,950USD£6,043GBP
- Clinical Trials
- April 2025
- 450 Pages
Global
From €4379EUR$5,000USD£3,801GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1314EUR$1,500USD£1,140GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1314EUR$1,500USD£1,140GBP
- Clinical Trials
- April 2025
- 70 Pages
Global
From €1314EUR$1,500USD£1,140GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1314EUR$1,500USD£1,140GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more